1858206-76-4
1858206-76-4
Chemical Structure
BTK inhibitor 17
- CAS No.: 1858206-76-4
- Formula:C25H24N6O3
- Molecular Weight:456.50
IUPAC Name: (R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one
InChIKey: QUYXPVXTKPTPCA-QGZVFWFLSA-N
SMILES: O=C1C(N([C@H]2CN(C(C=C)=O)CCC2)N=C3C4=CC=C(OC5=CC=CC=C5)C=C4)=C3C(N)=NN1
Biological Activity: BTK inhibitor 17 is a potent and orally active irreversible BTK inhibitor with an IC50 of 2.1 nM. BTK inhibitor 17 can be used for rheumatoid arthritis research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BTK inhibitor 17 | 99.53% | BTK inhibitor 17 is a potent and orally active irreversible BTK inhibitor with an IC50 of 2.1 nM. BTK inhibitor 17 can be used for rheumatoid arthritis research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
